Cart
sales@molnova.com
Otophylloside H
CAS No. 1015447-48-9
Otophylloside H( ——— )
Catalog No. M38747 CAS No. 1015447-48-9
Otophylloside H is a pregnane glycosides isolated from the roots of Cynanchum otophyllum. Otophylloside H can be used in epilepsy research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameOtophylloside H
-
NoteResearch use only, not for human use.
-
Brief DescriptionOtophylloside H is a pregnane glycosides isolated from the roots of Cynanchum otophyllum. Otophylloside H can be used in epilepsy research.
-
DescriptionOtophylloside H is a pregnane glycosides isolated from the roots of Cynanchum otophyllum. Otophylloside H can be used in epilepsy research.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1015447-48-9
-
Formula Weight1242
-
Molecular FormulaC60H90O27
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ma XX, et al. New pregnane glycosides from the roots of Cynanchum otophyllum. Steroids. 2007 Oct;72(11-12):778-86.?
molnova catalog
related products
-
OptoDArG
OptoDArG is a photoswitchable probe that has the activity to recognize lipid-gated pores by controlling TRPC3 channels and can be used as a tool to study the lipid sensing mechanism of TRPC channels.
-
VIP(6-28)(human, rat...
VIP(6-28)(human, rat, porcine, bovine) is an effective antagonist of the actions of exogenous vasoactive intestinal peptide (VIP) on cAMP.
-
Miriplatin hydrate
Miriplatin hydrate (SM-11355 (hydrate)) (MPT) is a novel platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC).
